Rotigotine

罗替高汀

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug NameRotigotine
Drug Alias NameRotigotinum罗替可丁罗替戈汀Rotigotina罗替高停 +[14] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine receptors agonists
TargetsDopamine receptors
Therapy Area/IndicationsSubstance-Related DisordersPain, PostoperativeKidney Failure, Chronic +[8] 
Global Approved IndicationsRestless Legs SyndromeParkinson Disease
Approved Indications in ChinaRestless Legs SyndromeParkinson Disease
Original Approved Country/TerritoryEU
Original Approved Date2006/02/15
Country/TerritoryCzechiaBelgiumCanada +[31] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesUcb Sa
China Registration ClassN/A

Develop Information

Active CompaniesMubadala Investment CompanyCBC Co LtdOtsuka Holdings Co Ltd +[6] 
Inactive CompaniesSchwarz Biosciences GmbhSandozUcb Biopharma Srl +[17] 
Active IndicationsSubstance-Related DisordersRestless Legs SyndromeParkinson Disease
Inactive IndicationsPain, PostoperativeKidney Failure, ChronicPerceptual Disorders +[5] 

Other Information

ATC CodeN04BC09
Related LinksWikipediaDrugBankKEGG